Search | IOVS | ARVO Journals

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Antisense oligonucleotide-based correction of deep-intronic ABCA4 splice mutations using patient-derived fibroblasts and photoreceptor precursor cells

Sarah Naessens; Rob W J Collin; Frauke Coppieters; Miriam Bauwens; Lonneke Duijkers; Irina Balikova; Bart P Leroy; Elfride De Baere; Alex Garanto

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4950. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

Delivery and deployment of a ciliary actin dynamics module by PCARE drives the neogenesis of phototransductive membrane disks

Rob W J Collin; Julio Cesar Corral Serrano; Jeroen van Reeuwijk; Anita DM Hoogendoorn; Renate AA Ruigrok; Adem Yildirim; Stef JF Letteboer; Lonneke Duijkers; Sanae Sakami; Krzysztof Palczewski; Karsten Boldt; Uwe Wolfrum; Marius Ueffing; Alex Garanto; Ronald Roepman

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4979. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2017

Deciphering the molecular network surrounding ZNF408 in the regulation of retinal angiogenesis

Dyah W Karjosukarso; Sebastianus HC van Gestel; Jieqiong Qu; Evelyn N Kouwenhoven; Lonneke Duijkers; Huiqing Zhou; Rob W J Collin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2051. doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Antisense oligonucleotide delivery is an effective therapeutic approach for CEP290 -associated LCA

Alejandro Garanto; Daniel C Chung; Lonneke Duijkers; Julio Cesar Corral Serrano; Muriël Messchaert; Ru Xiao; Jean Bennett; Luk H Vandenberghe; Rob Collin

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi: https://doi.org/

ARVO Annual Meeting Abstract April 2014

AAV-mediated antisense oligonucleotide-based therapy for CEP290 -associated LCA

Alejandro Garanto; Lonneke Duijkers; Ru Xiao; Luk H Vandenberghe; Rob W J Collin

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3312. doi: https://doi.org/

Advertisement